Press Release

Home / Press Release (Page 2)

BERLIN, Germany, May 8th, 2019 – Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) (FSE: C4T), has granted incentive stock options to purchase up to 1,020,000 common shares of Chinook to its directors, officers, employees, and consultants in Germany, Switzerland and Canada pursuant to its stock option plan, including 655,000 options issued to directors and officers. Each option vests immediately, has an exercise price of $0.15 per share and is valid for a period of one year from the date of issuance.   Chinook Tyee Industry Limited Chinook is...

BERLIN, Germany, May 6th, 2019 – Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) (FSE: C4T), announces a non-brokered placement of up to 10,000,000 common shares at a price of $0.15 per share for gross proceeds of up to $1.5-million for working capital purposes. All securities issued pursuant to the offering will be subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws. Chinook expects to complete...

BERLIN, GERMANY, May 3rd, 2019 | Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), (FSE: C4T) is pleased to announce that its Class A Voting Common Shares will be listed for trading on the Frankfurt Stock Exchange (FSE), also known as Börse Frankfurt, under the trading symbol "C4T" (WKN: A12DYZ, ISIN: CA16961T2083). The market maker representing Chinook in Germany is Baader Bank AG. "Europe is set to become the world's largest legal cannabis market over the next five years as it is home to more than 740...

ERFURT, Germany and EDMONTON, Feb. 7, 2019 /CNW/ - AMP Alternative Medical Products GmbH ("AMP"), a subsidiary of Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), has entered into a non-binding Memorandum of Understanding Production Supply Agreement ("MOU") with Pure Life Cannabis Corporation ("PLCC"), a late-stage Health Canada applicant to become a licensed producer of cannabis ("LP") based in Edmonton, Alberta. PLCC is in the process of building a 27,280 square foot Phase 1 facility, which it anticipates can produce approximately 2,000 kilograms of EU-GMP cannabis flower annually and...

BERLIN, Feb. 5, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) is an investment finance company with two European subsidiaries, AMP Alternative Medical Products GmbH based in Erfurt, Germany and Mercury Partners & Company plc based in Valletta, Malta. Chinook has 10,217,796 fully diluted shares issued and outstanding and net investment assets of over $2.0 million (unaudited) as of September 30th, 2018. About AMP Alternative Medical Products ("AMP")AMP Alternative Medical Products GmbH, is a biopharmaceutical company based in the German state of Thuringia and provides medical cannabis formulations and...

ERFURT, GERMANY, January 2nd, 2019 | Chinook Tyee Industry Limited (the "Company") (TSXV: XCX) announces that Dr. Stefan Feuerstein and Messrs. Alex Blodgett, Claudio Morandi and Ken MacLeod were elected to the board of directors at the Company’s shareholder meeting. Dr. Stefan Feuerstein who is also Managing Director of AMP Alternative Medical Products GmbH, a wholly owned subsidiary of the Company, was appointed President while Mr. Blodgett was appointed Chief Executive Officer of the Company. About AMP Alternative Medical Products AMP Alternative Medical Products GmbH, is a...

ERFURT, Germany, Dec. 3, 2018 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) announces that AMP Alternative Medical Products GmbH ("AMP"), its wholly-owned subsidiary, has entered into a €500,000 Series B drawdown loan facility provided by Taiga Atlas plc ("Taiga Atlas").  AMP completed a €75,000 Series A equity financing with Chinook during 2018. AMP is a German based biopharmaceutical company developing medical cannabis formulations and dose delivery systems for patients in Germany.  Proceeds from the financing will be used to build out AMP's German sales and distribution supply...